"65162-061-32" National Drug Code (NDC)

NDC Code	65162-061-32
Package Description	360 TABLET in 1 BOTTLE (65162-061-32)
Product NDC	65162-061
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Ritonavir
Non-Proprietary Name	Ritonavir
Dosage Form	TABLET
Usage	ORAL
Start Marketing Date	20180921
Marketing Category Name	ANDA
Application Number	ANDA208890
Manufacturer	Amneal Pharmaceuticals LLC
Substance Name	RITONAVIR
Strength	100
Strength Unit	mg/1
Pharmacy Classes	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]